Showing results (131-140 of 143) with videos related to
Sort By:
Pageof 15
Neurology|February 20, 1999
HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathyD B Clifford, C Yiannoutsos, M Glicksman, et al.Neurology|June 14, 2006
HIV neuropathy natural history cohort study: assessment measures and risk factorsD M Simpson, D Kitch, S R Evans, et al.Pain|September 21, 2010
Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathyJ Robinson-Papp, S Morgello, F Vaida, et al.The Clinical Neuropsychologist|June 20, 2012
Defining neurocognitive impairment in HIV: deficit scores versus clinical ratingsK Blackstone, D J Moore, D R Franklin, et al.The Journal of Infectious Diseases|June 3, 1999
Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials GroupJ M Jacobson, J Spritzler, L Fox, et al.Neurology|June 15, 2007
Correlates of epidermal nerve fiber densities in HIV-associated distal sensory polyneuropathyL Zhou, D W Kitch, S R Evans, et al.Journal of Neurovirology|September 18, 2014
Brain morphometric correlates of metabolic variables in HIV: the CHARTER studyS L Archibald, J A McCutchan, C Sanders, et al.Neurology|October 10, 2001
Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathyG Schifitto, C Yiannoutsos, D M Simpson, et al.Journal of the International Neuropsychological Society : JINS|November 26, 2011
Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioningK Blackstone, D J Moore, R K Heaton, et al.Neurology|March 17, 2000
A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291J C McArthur, C Yiannoutsos, D M Simpson, et al.Pageof 15